Pomerantz LLP

Pomerantz LLP is one of the nation’s foremost specialists in corporate, securities, antitrust, and

For 85 years, Pomerantz LLP has championed the rights of defrauded investors and consumers, recovering well over $1 billion on their behalf. We consistently shape the law, having won landmark decisions that expanded and protected investor and consumer rights, and initiated historic corporate governance reforms. Pomerantz is a recognized leader in securities and corporate governance litigation. The

Firm monitors the portfolios of some of the most influential institutional investors worldwide, monitoring assets in excess of $6.8 trillion, and growing. We also have an accomplished team dedicated to representing the interests of shareholders in M&A litigation, and have earned a national reputation for our expertise in antitrust litigation. Our clients receive the complimentary benefit of our innovative PomTrack portfolio monitoring system. PomTrack protects institutional investor portfolios by identifying losses due to corporate wrongdoing, determining our clients’ eligibility to participate in settled securities cases, providing claims filing assistance, and more. This ongoing protection—and the peace of mind it delivers—is another way that Pomerantz earns the trust of its clients every day. Pomerantz is headquartered in New York City, with offices in Chicago, Los Angeles, and Weston, Florida.

05/21/2026

Pomerantz has been appointed Co-Lead Counsel in a securities class action against Beyond Meat, Inc., a producer of plant-based meat products.

The lawsuit alleges that Beyond Meat misled investors about its operations, financial health, and the recording of significant asset impairment charges attributable to the company's long-lived assets.

When the truth began to emerge, the company revealed a $77.4 million impairment charge, and its stock declined sharply across multiple disclosures, including a drop of over 23% in a single day.

05/20/2026

has achieved a key victory in an investor suit against Google and its parent company, Alphabet, Inc., led by Partners Emma Gilmore and Jeremy A. Lieberman. A California federal judge has granted class certification for Alphabet investors in the high-profile litigation.

The suit alleges that Google and CEO Sundar Pichai misled shareholders about Google’s digital advertising practices, including preferential treatment of its own ad exchange and a secret deal with Facebook.

Read more here: https://pomlaw.com/news/pomerantz-llp-secures-class-certification-for-alphabet-inc-investors/

05/14/2026

Dalip Singh Saund was the first Asian American, Indian American, and Sikh American to be elected to the U.S. Congress in 1957.

Before his election, Singh Saund fought against discriminatory laws that prevented Southeast Asians from becoming U.S. citizens. His efforts eventually led to the passing of the Luce-Celler Act of 1946, which allowed more South Asians to immigrate to the U.S. and gain citizenship.

In Congress, he served three terms and was known as a champion of small farmers and civil rights legislation.

05/13/2026

In the newest edition of , Of Counsel Rupita Chakraborty shares details about her path to securities litigation, the role of mentorship in her development, and advice for attorneys looking to make their mark in the legal field.

Read more here: https://bit.ly/4tB94fw

05/12/2026

Pomerantz has been named Co-Lead Counsel in a securities class action against Ramaco Resources, Inc., a rare earth and metallurgical coal development company.

The suit alleges that Ramaco misled investors regarding the progress and operations of one of its mineral mines, believed to contain rare earth elements. An investigative market report conducted by Wolfpack Research revealed that Brook Mine was essentially a hoax, as no significant or active mining activity had commenced since groundbreaking.

When the truth emerged, Ramaco's stock fell 9.6%, causing significant losses for investors.

05/06/2026

In the latest , Associate Guy Yedwab examines the ’s recent move to restrict shareholders from filing voluntary Notices of Exempt Solicitation, limiting a key avenue for investor communication and participation in the proxy process.

Read more here: https://bit.ly/3PiDt4c

05/05/2026

Pomerantz has been named Co-Lead Counsel in a securities class action against PomDoctor, Ltd., a Chinese online medical services platform.

The suit alleges that PomDoctor utilized social media to orchestrate an illegal "pump-and-dump" promotion scheme to boost its stock. Impersonators claiming to be financial advisors touted the company on social media with sensational, but baseless claims to create a buying frenzy among retail investors.

When the truth was revealed, PomDoctor's share price crashed by nearly 91%, causing significant losses for investors.

05/01/2026

Judge Lorna G. Schofield is the first Filipina American to serve as an Article III federal district judge in the U.S., having been appointed by former President Barack Obama in 2012.

Throughout her legal career, Judge Schofield specialized in complex civil litigation and white-collar criminal defense, as well as holding a number of leadership positions with the American Bar Association.

04/30/2026

Pomerantz has been appointed Co-Lead Counsel in a securities class action against Gauzy Ltd., a smart glass technology company.
The case alleges that Gauzy and its executives made misleading statements regarding the company’s financial condition, specifically by failing to disclose to investors that three of the company’s French subsidiaries lacked the financial means to pay their debts when they were due.
As a result, the company’s share price fell nearly 50% over the course of two consecutive trading days, leading to substantial losses for investors.

04/29/2026

Pomerantz has secured a significant win in the class action against Humacyte Inc., as the Court largely denied the Defendants’ motion to dismiss and allowed the core product safety fraud claims to proceed.
Led by Partner Matthew Tuccillo, with support from Associate Zachary Denver, the court ruled that Pomerantz sufficiently pled that the company and several top executives misled investors regarding its vascular implant and clinical data. The court dismissed two secondary frauds, without prejudice to repleading them. Pomerantz and co-counsel are overseeing the case into discovery.

04/23/2026

In the latest , Pomerantz Associate Dean Ferrogari examines a growing circuit split now before the U.S. Supreme Court on whether the SEC must demonstrate investor harm to obtain disgorgement, an issue with implications for enforcement strategy and regulatory authority.

Read more here: https://bit.ly/4vN9LVf

Address

600 3RD Avenue
New York, NY
10016

Website

http://www.pomlaw.com/

Alerts

Be the first to know and let us send you an email when Pomerantz LLP posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Pomerantz LLP:

Shortcuts

Featured

The Law Office of Richard M. Kenny
363 7th Avenue 16th Floor

Want your practice to be the top-listed Law Practice in New York?